Course Provider
Learning Objectives
Upon completion of this activity, participants should be better able to apply the latest clinical evidence on CAR T-cell therapies to individualize treatment decision-making for patients with hematologic malignancies
Upon completion of this activity, participants should be better able to integrate effective strategies for shared decision-making and patient-centered care to improve patient-provider communication and collaboration regarding treatment with CAR T-cell therapy
Upon completion of this activity, participants should be better able to employ interprofessional approaches to enhance coordinated care for CAR T-cell therapy referral, administration, and follow-up for appropriate patients with hematologic malignancies to optimize outcomes